BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28204871)

  • 1. The role of beta-catenin mutation and SOX9 expression in sex cord-stromal tumours of the testis.
    Bremmer F; Behnes CL; Schildhaus HU; Gaisa NT; Reis H; Jarry H; Radzun HJ; Stroebel P; Schweyer S
    Virchows Arch; 2017 Apr; 470(4):421-428. PubMed ID: 28204871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Localization of β-Catenin in Sertoli Cell Tumors and Other Sex Cord-Stromal Tumors of the Testis: An Immunohistochemical Study of 87 Cases.
    Zhang C; Ulbright TM
    Am J Surg Pathol; 2015 Oct; 39(10):1390-4. PubMed ID: 26034868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic and molecular characterizations of Sertoli cell tumor, not otherwise specified of the testis].
    Zhao M; Zhao DH; He HY; Zhang X; Ru GQ; He XL; Wang Z; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):505-510. PubMed ID: 29996314
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
    Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
    Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testis.
    Perrone F; Bertolotti A; Montemurro G; Paolini B; Pierotti MA; Colecchia M
    Am J Surg Pathol; 2014 Jan; 38(1):66-71. PubMed ID: 24061522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
    Buell-Gutbrod R; Ivanovic M; Montag A; Lengyel E; Fadare O; Gwin K
    Pediatr Dev Pathol; 2011; 14(5):391-5. PubMed ID: 21682576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
    Devouassoux-Shisheboran M; Deschildre C; Mauduit C; Berger G; Mejean-Lebreton F; Bouvier R; Droz JP; Fénichel P; Benahmed M
    Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of SOX9 protein in immature, mature, and neoplastic canine Sertoli cells.
    Banco B; Palmieri C; Sironi G; Fantinato E; Veronesi MC; Groppetti D; Giudice C; Martignoni B; Grieco V
    Theriogenology; 2016 May; 85(8):1408-1414.e1. PubMed ID: 26777558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of immunostaining for S-100 protein subunits in gonadal sex cord-stromal tumors, with emphasis on the large-cell calcifying Sertoli cell tumor of the testis.
    Tanaka Y; Carney JA; Ijiri R; Kato K; Miyake T; Nakatani Y; Misugi K
    Hum Pathol; 2002 Mar; 33(3):285-9. PubMed ID: 11979368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian sex cord-stromal tumours and their mimics.
    Young RH
    Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
    Iczkowski KA; Bostwick DG; Roche PC; Cheville JC
    Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary signet ring stromal tumor of the testis: a study of 13 cases indicating their phenotypic and genotypic analogy to pancreatic solid pseudopapillary neoplasm.
    Michalova K; Michal M; Kazakov DV; Sedivcova M; Hes O; Hadravsky L; Agaimy A; Tretiakova M; Bacchi C; Hartmann A; Kuroda N; Bulimbasic S; Coric M; Antic T; Michal M
    Hum Pathol; 2017 Sep; 67():85-93. PubMed ID: 28739499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review.
    Zhu P; Duan Y; Ao Q; Wang G
    Cancer Res Treat; 2018 Oct; 50(4):1452-1457. PubMed ID: 29169232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors.
    Arnesen C; Eich ML; Pena MDCR; Cappel JR; Schwartz L; Rais-Bahrami S; Faraj SF; Prieto Granada C; Gordetsky JB
    Am J Surg Pathol; 2020 Jan; 44(1):61-67. PubMed ID: 31498176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Morphologic and Immunohistochemical Comparison of Nuclear β-Catenin Expressing Testicular Sertoli Cell Tumors and Pancreatic Solid Pseudopapillary Neoplasms Supporting Their Continued Separate Classification.
    Kao CS; Ulbright TM
    Am J Surg Pathol; 2020 Aug; 44(8):1082-1091. PubMed ID: 32604170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microcystic stromal tumour of the ovary: frequent mutations of β-catenin (CTNNB1) in six cases.
    Bi R; Bai QM; Yang F; Wu LJ; Cheng YF; Shen XX; Cai X; Zhou XY; Yang WT
    Histopathology; 2015 Dec; 67(6):872-9. PubMed ID: 25913412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New immunohistochemical markers in testicular tumors.
    Vidal-Jimenez A
    Anal Quant Cytol Histol; 2007 Dec; 29(6):377. PubMed ID: 18225394
    [No Abstract]   [Full Text] [Related]  

  • 20. Microcystic stromal tumour of testis.
    Hoogland M; Bleumer I; Suurmeijer A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35304356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.